JDRF welcomes leading medical researcher to Board to support continued research excellence

July 19, 2021

JDRF Australia are delighted to welcome Professor Fabienne Mackay to the Board of JDRF Australia. Professor Mackay, who joined the Board at the June 2021 Board meeting, will also play an important role on JDRF’s Board Research Committee, evaluating and ensuring JDRF continues to support the best local research into type 1 diabetes (T1D).  

Prof. Mackay obtained her PhD from Louis Pasteur University in Strasbourg, France and has more than 25 years of experience in leadership roles, both leading research endeavours and managing large-scale research institutes. She is currently Director and CEO of the world renowned QIMR Berghofer Medical Research Institute based in Queensland. She is also an Honorary Professor at both the University of Queensland and University of Melbourne.  

Prof. Mackay has a particular interest in autoimmune diseases and has authored over 139 articles, reviews and book chapters. Commenting on the appointment, CEO of JDRF Australia, Mike Wilson OAM, highlights that Prof. Mackay will provide a fresh and valuable contribution to JDRF’s mission.  

“On behalf of JDRF Australia and the wider T1D community, I welcome Fabienne to the Board. We are fortunate to have someone of her skills and experience working in support of our mission. She has an ideal mix of relevant scientific experience, global connections and an understanding of the challenges of delivering change in chronic health conditions, and we very much look forward to her involvement.”